Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-042220

Director sold 15,009 shares at $25.00 ($375,225)

  • Director acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
GREER R SCOTT Director 2020-07-09 Option exercise +40,000 $9.24 $369,600 191,583 D
GREER R SCOTT Director 2020-07-09 Sale −15,009 $25.00 $375,225 176,574 D
Derivatives
GREER R SCOTT Director 2020-07-09 Option exercise · Stock Option −40,000 0 D
Open-market sales · 15,009 sh · avg $25.00 · $375,225
Loading xslF345X03/doc4.xml…